EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Overcoming Tumor Hypoxia in Photodynamic Therapy: A Comprehensive Review of Oxygen-Delivery Carriers and Type I Photosensitizers

Dorota Bartusik-Aebisher iD, Izabela Rudy, Kacper Rogóż iD, Jakub Szpara, Aleksandra Kawczyk-Krupka, David Aebisher iD

International Journal of Molecular Sciences · 25.05.2026 · 27 (11) · 4748

DOI: 10.3390/ijms27114748 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.05.2026. Verfasst von Dorota Bartusik-Aebisher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and General Chemistry, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-959 Rzeszów, Poland. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photochemotherapy, Oxygen, Tumor Hypoxia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypoxia is one of the most important factors limiting the effectiveness of modern anticancer therapies, particularly photodynamic therapy (PDT). The hypoxia of the tumor microenvironment results from abnormal angiogenesis and the high metabolic demand of cancer cells, which leads to reduced oxygen availability necessary for generating reactive oxygen species (ROS). Consequently, conventional therapeutic approaches, mainly based on the type II PDT mechanism, show limited effectiveness under hypoxic conditions. In response to these limitations, strategies are being developed to increase oxygen availability within the tumor. Of particular importance are nanocarriers based on perfluorocarbons (PFCs), which, due to their high gas solubility, can effectively transport and release oxygen in the tumor microenvironment. Research indicates that the use of such systems leads to improved PDT efficiency by increasing the production of singlet oxygen and enhancing cancer cell damage. Parallelly, alternative approaches independent of high oxygen concentration, including type I photosensitizers, are being developed. Unlike classical type II mechanisms, they generate free radicals through electron transfer reactions, which allows effective action even under conditions of significant hypoxia. This approach significantly expands the possibilities of using PDT in the treatment of tumors with low oxygen levels. Current research directions focus on integrating various therapeutic strategies to achieve a synergistic effect. Hybrid systems combining oxygen delivery (e.g., using PFCs) with the use of type I photosensitizers and other treatment methods, such as chemotherapy or immunotherapy, show the greatest clinical potential. Such multifunctional approaches simultaneously allow improving tumor oxygenation and increasing the efficiency of ROS generation, which makes them a promising strategy for the future of anticancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photosensitizing AgentsPhotochemotherapyOxygenTumor HypoxiaNeoplasmsHumansAnimalsReactive Oxygen SpeciesTumor MicroenvironmentFluorocarbonsDrug Carriers

Stichwörter der Autor:innen

nanomedicineperfluorocarbon oxygen carriersphotodynamic therapytumor hypoxiatype I photosensitizers

Substanzen

Photosensitizing AgentsOxygenReactive Oxygen SpeciesFluorocarbonsDrug Carriers

Autor:innen und Institutionen

  • Department of Biochemistry and General Chemistry, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-959 Rzeszów, Poland.
  • Student Scientific Club of Biochemists URCell, Department of Biochemistry and General Chemistry, Faculty of Medicine, Collegium Medicum, University of Rzeszów, 35-959 Rzeszów, Poland.
  • Department of Internal Diseases, Angiology and Physical Medicine, Center for Laser Diagnostics and Therapy, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.
  • Department of Photomedicine and Physical Chemistry, Medical College, University of Rzeszów, 35-959 Rzeszów, Poland.

ORCID-Profile: Dorota Bartusik-Aebisher, Kacper Rogóż, David Aebisher

Zitieren

APA

Bartusik-Aebisher, D., Rudy, I., Rogóż, K., Szpara, J., Kawczyk-Krupka, A., & Aebisher, D. (2026). Overcoming Tumor Hypoxia in Photodynamic Therapy: A Comprehensive Review of Oxygen-Delivery Carriers and Type I Photosensitizers. International Journal of Molecular Sciences, 27(11), 4748. https://doi.org/10.3390/ijms27114748

Vancouver

Bartusik-Aebisher D, Rudy I, Rogóż K, Szpara J, Kawczyk-Krupka A, Aebisher D. Overcoming Tumor Hypoxia in Photodynamic Therapy: A Comprehensive Review of Oxygen-Delivery Carriers and Type I Photosensitizers. International Journal of Molecular Sciences. 2026;27(11):4748. doi:10.3390/ijms27114748

BibTeX
@article{BartusikAebisher2026,
  author = {Bartusik-Aebisher, Dorota and Rudy, Izabela and Rogóż, Kacper and Szpara, Jakub and Kawczyk-Krupka, Aleksandra and Aebisher, David},
  title = {Overcoming Tumor Hypoxia in Photodynamic Therapy: A Comprehensive Review of Oxygen-Delivery Carriers and Type I Photosensitizers},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {11},
  pages = {4748},
  doi = {10.3390/ijms27114748}
}
Kostenlos starten →